Clinical Trial Update: BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women [NA]

View source ↗

Summary

Clinical trial update for two devices, BTL-699-2 and HPM-6000UF, investigating improvement of depressive symptoms and urinary incontinence in postpartum and ear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression
• Urinary Incontinence

Drugs mentioned

• BTL-699-2
• HPM-6000UF

Snippet

Sponsor: BTL Industries Ltd. | Conditions: Depressive Symptoms, Urinary Incontinence | NA | Status: RECRUITING